Stengone Carmine N. 4
4 · KIORA PHARMACEUTICALS INC · Filed Sep 12, 2024
Insider Transaction Report
Form 4
Stengone Carmine N.
Director
Transactions
- Purchase
Common Stock
2024-09-11$3.68/sh+1,250$4,600→ 1,250 total
Footnotes (1)
- [F1]The shares were purchased in multiple transactions at prices ranging from $3.65 to $3.73. The reported price of $3.68 represents the volume weighted average price for the reported transaction. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.